Gomisin N ameliorates autophagy-neuroinflammation imbalance in Parkinson's disease models via modulating the ATG16L1/NLRP3 axis
Phytomedicine · 2026-11 · 162 · 158795
DOI: 10.1016/j.phymed.2026.158795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026-11. Verfasst von Chengfu Su und 14 weiteren Autor:innen. Beteiligte Einrichtung: Mr. & Mrs. Ko Chi-Ming Centre for Parkinson's Disease Research (CPDR), Golden Meditech Centre for NeuroRegeration Science (GCNS), School of Chinese M…. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Hong Kong Baptist University, Science, Technology and Innovation Commission of Shenzhen Municipality, Health and Medical Research Fund.
Abstract (Originalsprache)
BACKGROUND: Parkinson's disease (PD) is characterized by dopaminergic neuron loss, α-synuclein accumulation, and sustained neuroinflammation. Autophagy can remove pathogenic α-synuclein and restrain NLR family pyrin domain containing 3 (NLRP3) inflammasome activation. Gomisin N (GN), a lignan from Schisandra chinensis, is neuroprotective, but its mechanism in PD remains incompletely defined. PURPOSE: To determine whether GN protects against PD-like pathology by coordinating autophagy and neuroinflammation through autophagy related 16 like 1 (ATG16L1). METHODS: Neuronal and microglial cell models, as well as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice with ATG16L1 knockdown, were assessed through pharmacological, behavioral, biochemical, and immunohistochemical analyses. RESULTS: GN crossed the blood-brain barrier, improved motor performance, preserved dopaminergic neurons, reduced α-synuclein oligomers, and suppressed NLRP3/caspase-1/interleukin-1β signaling in MPTP-treated mice. Mechanistically, GN increased the mRNA and protein levels of ATG16L1, enhanced ATG16L1-ATG5 complex formation, and promoted autophagic flux and lysosomal function without canonical mTORC1 inhibition Notably, we uncovered a vicious cycle where α-synuclein overexpression suppressed ATG16L1, impairing autophagy; GN effectively rescued this compromised ATG16L1 expression, facilitating targeted α-synuclein degradation. In microglia, GN blunted NLRP3 inflammasome activation by promoting the ATG16L1-dependent autophagic degradation of essential inflammasome components. Crucially, ATG16L1 knockdown completely abrogated the neuroprotective and anti-inflammatory effects of GN both in vitro and in vivo. CONCLUSION: GN is a brain-penetrant preclinical candidate that links ATG16L1-dependent autophagy with α-synuclein clearance and NLRP3 inflammasome suppression in PD models.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mr. & Mrs. Ko Chi-Ming Centre for Parkinson's Disease Research (CPDR), Golden Meditech Centre for NeuroRegeration Science (GCNS), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong Special Administrativ…
- School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Förderung
- Hong Kong Baptist University
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Health and Medical Research Fund
- National Natural Science Foundation of China
Zitieren
APA
Su, C., Deng, Z., Ying, K. Y., Liu, J., Guan, X., Kan, Y., Xu, X., Iyaswamy, A., Lu, K., Lu, J., Wu, J., Zhu, J., Cheung, K. H., Li, M., & Song, J. (2026). Gomisin N ameliorates autophagy-neuroinflammation imbalance in Parkinson's disease models via modulating the ATG16L1/NLRP3 axis. Phytomedicine, 162, 158795. https://doi.org/10.1016/j.phymed.2026.158795
Vancouver
Su C, Deng Z, Ying KY, Liu J, Guan X, Kan Y, et al. Gomisin N ameliorates autophagy-neuroinflammation imbalance in Parkinson's disease models via modulating the ATG16L1/NLRP3 axis. Phytomedicine. 2026;162:158795. doi:10.1016/j.phymed.2026.158795
BibTeX
@article{Su2026,
author = {Su, Chengfu and Deng, Zhiqiang and Ying, Ka Yee and Liu, Jia and Guan, Xinjie and Kan, Yuxuan and Xu, Xiaogang and Iyaswamy, Ashok and Lu, Kejia and Lu, Jing and Wu, Jiaxi and Zhu, Jianguang and Cheung, King-Ho and Li, Min and Song, Juxian},
title = {Gomisin N ameliorates autophagy-neuroinflammation imbalance in Parkinson's disease models via modulating the ATG16L1/NLRP3 axis},
journal = {Phytomedicine},
year = {2026},
volume = {162},
pages = {158795},
doi = {10.1016/j.phymed.2026.158795}
}
EUVIMED